The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KIRROS: A phase II trial in progress of first-line atezolizumab (atezo) with or without bevacizumab (bev) in patients with unresectable hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis.
 
Amit Singal
Consulting or Advisory Role - AstraZeneca; Bayer; Boston Scientific; Eisai; Elevar Therapeutics; Exelixis; Genentech; HistoSonics; Merck; Sirtex Medical
 
Kristen Spencer
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Caris Life Sciences; Exelixis; Genentech/Roche
Speakers' Bureau - American Cancer Society
Research Funding - Winn CDA
Travel, Accommodations, Expenses - ASCO; Cholangiocarcinoma Foundation
 
Laura Kulik
Consulting or Advisory Role - ASCO GI HCC; Bayer; Chronic Liver Disease Foundation; Eisai; Exelixis; Focus Medical Communications; Gala Therapeutics; Genentech; HCC TAG; Health and Wellness Partners; MJH Healthcare Holdings, LLC; Peerview Operation Services America, LLC; Vereo Communications
 
Augusto Villanueva
Stock and Other Ownership Interests - Atzeyo; Espervita Therapeutics
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; FirstWorld; Genentech; NGM Biopharmaceuticals; Pioneering Medicines; Roche
Research Funding - Eisai
Patents, Royalties, Other Intellectual Property - National Institute of Health (NIH)
 
Renuka Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Bayer; Eisai; Exelixis; Genentech; Incyte; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sandoz; Sun pharma; Tersera
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - AstraZeneca; Genentech; Replimune
 
Shilpa Chakalakal
No Relationships to Disclose
 
Rucha Kothari
Employment - Genentech
Stock and Other Ownership Interests - Care Dx; Roche
 
Jinnie Ko
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Norelle Reilly
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Thomas Stark
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Anthony El-Khoueiry
Honoraria - Agenus; AstraZeneca/MedImmune; Bristol-Myers Squibb; EISAI; Elevar Therapeutics; Exelixis; Merck; Qurient; Roche/Genentech; Senti Biosciences; SERVIER; TERUMO
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Bristol-Myers Squibb; Eisai; Elevar Therapeutics; Exelixis; Genentech; Merck; Qurient; Roche; Senti Biosciences; SERVIER; TERUMO
Research Funding - Astex Pharmaceuticals; AstraZeneca; Auransa; Fulgent Genetics
Travel, Accommodations, Expenses - Affimed Therapeutics